BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kraft JC, Treuting PM, Ho RJY. Indocyanine green nanoparticles undergo selective lymphatic uptake, distribution and retention and enable detailed mapping of lymph vessels, nodes and abnormalities. J Drug Target 2018;26:494-504. [PMID: 29388438 DOI: 10.1080/1061186X.2018.1433681] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Kim J, Archer PA, Thomas SN. Innovations in lymph node targeting nanocarriers. Semin Immunol 2021;:101534. [PMID: 34836772 DOI: 10.1016/j.smim.2021.101534] [Reference Citation Analysis]
2 Gao Y, Kraft JC, Yu D, Ho RJY. Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy. Eur J Pharm Biopharm 2019;138:75-91. [PMID: 29678735 DOI: 10.1016/j.ejpb.2018.04.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
3 Hyuga T, Hashimoto D, Matsumaru D, Kumegawa S, Asamura S, Suzuki K, Katayama KI, Nakamura S, Nakai H, Yamada G. Evaluation of surgical procedures of mouse urethra by visualization and the formation of fistula. Sci Rep 2020;10:18251. [PMID: 33106510 DOI: 10.1038/s41598-020-75184-5] [Reference Citation Analysis]
4 Mu Q, Yu J, Griffin JI, Wu Y, Zhu L, McConnachie LA, Ho RJY. Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis. PLoS One 2020;15:e0228557. [PMID: 32142553 DOI: 10.1371/journal.pone.0228557] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Yanmin X, Xuyang Z, Wen Y, Suihuai Y, Sinan L. Study on the Design and Optimization of a Portable Monitoring and Auxiliary Treatment Device for Upper Extremity Lymphedema-Focus on the Rehabilitation Function of the Device. Front Bioeng Biotechnol 2021;9:656716. [PMID: 33869161 DOI: 10.3389/fbioe.2021.656716] [Reference Citation Analysis]
6 McConnachie LA, Kinman LM, Koehn J, Kraft JC, Lane S, Lee W, Collier AC, Ho RJY. Long-Acting Profile of 4 Drugs in 1 Anti-HIV Nanosuspension in Nonhuman Primates for 5 Weeks After a Single Subcutaneous Injection. J Pharm Sci 2018;107:1787-90. [PMID: 29548975 DOI: 10.1016/j.xphs.2018.03.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
7 Halling Folkmar Andersen A, Tolstrup M. The Potential of Long-Acting, Tissue-Targeted Synthetic Nanotherapy for Delivery of Antiviral Therapy Against HIV Infection. Viruses 2020;12:E412. [PMID: 32272815 DOI: 10.3390/v12040412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Duan M, Han D, Shen W, Chang K, Wang X, Gao N, Du J. Preparation of the Biodegradable Lymphatic Targeting Imaging Agent Based on the Indocyanine Green Mesoporous Silicon System. Front Chem 2022;10:847929. [DOI: 10.3389/fchem.2022.847929] [Reference Citation Analysis]
9 Koehn J, Iwamoto JF, Kraft JC, McConnachie LA, Collier AC, Ho RJY. Extended cell and plasma drug levels after one dose of a three-in-one nanosuspension containing lopinavir, efavirenz, and tenofovir in nonhuman primates. AIDS 2018;32:2463-7. [PMID: 30102655 DOI: 10.1097/QAD.0000000000001969] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
10 Olmeda D, Cerezo-Wallis D, Castellano-Sanz E, García-Silva S, Peinado H, Soengas MS. Physiological models for in vivo imaging and targeting the lymphatic system: Nanoparticles and extracellular vesicles. Adv Drug Deliv Rev 2021;175:113833. [PMID: 34147531 DOI: 10.1016/j.addr.2021.113833] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
11 Perazzolo S, Shen DD, Ho RJY. Physiologically Based Pharmacokinetic Modeling of 3 HIV Drugs in Combination and the Role of Lymphatic System after Subcutaneous Dosing. Part 2: Model for the Drug-combination Nanoparticles. J Pharm Sci 2021:S0022-3549(21)00552-9. [PMID: 34673094 DOI: 10.1016/j.xphs.2021.10.009] [Reference Citation Analysis]
12 Polomska AK, Proulx ST. Imaging technology of the lymphatic system. Adv Drug Deliv Rev 2021;170:294-311. [PMID: 32891679 DOI: 10.1016/j.addr.2020.08.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 18.0] [Reference Citation Analysis]
13 Han T, Ji Y, Cui J, Shen W. Inflow Occlusion Combined With Bleomycin Sclerotherapy for Management of Macro/Mixed Cystic Lymphatic Malformation in Children. Front Pediatr 2021;9:749983. [PMID: 34631633 DOI: 10.3389/fped.2021.749983] [Reference Citation Analysis]
14 Hajmohammadi Z, Fattahi R, Zarei-behjani Z, Hosseinzadeh S. Carbon nanoparticles for medicine: current and future. Bull Mater Sci 2022;45. [DOI: 10.1007/s12034-021-02582-4] [Reference Citation Analysis]